tiprankstipranks

Maha Katabi Insider Profile

11 Followers
Maha Katabi, Director at Vera Therapeutics, holds 2.79M shares in Vera Therapeutics (Ticker: VERA), holds 0.00 shares in RayzeBio, Inc. (Ticker: RYZB), holds 3.76M shares in Aerovate Therapeutics (Ticker: AVTE). Most recently, Maha Katabi Sold ― shares of Vera Therapeutics on Mar 25, 2024 for an estimated value of 34.10M.
tipranks
Maha Katabi

Maha Katabi
Vera Therapeutics (VERA)
Director

Ranked #36,730 out of 100,202 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+4.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$129M
92.60%
7.40%
A breakdown of Maha Katabi's holdings

Insider Roles

Vera Therapeutics
(VERA)
Director
Aerovate Therapeutics
(AVTE)
Director, Ten Percent Owner
Roles that Maha Katabi holds in companies

Most Profitable Insider Trade

Stock:
Vera Therapeutics
(VERA)
Rating:Informative Buy
Date:May 18, 2021 - May 18, 2022
Return:+32.80%
The most profitable trade made by Maha Katabi

Maha Katabi's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vera Therapeutics
Mar 25, 2024
Director
Informative Sell
34.10M
$119.02M
Aerovate Therapeutics
Jul 06, 2021
Director, Ten Percent Owner
Informative Buy
5.00M
$9.51M
RYZB
RayzeBio, Inc.
Feb 27, 2024
Uninformative Sell
151.22M
$0.00
List of latest transactions for each holding click on a transaction to see Maha Katabi's performance on stock

Maha Katabi insider profile FAQ

What is the percentage of profitable transactions made by Maha Katabi?
The percentage of profitable transactions made by Maha Katabi is 50%.
    What is the average return per transaction made by Maha Katabi?
    The average return per transaction made by Maha Katabi is 4.80%.
      What stocks does Maha Katabi hold?
      Maha Katabi holds: VERA, AVTE, RYZB stocks.
        What was Maha Katabi’s latest transaction?
        Maha Katabi latest transaction was an Informative Sell of $34.10M.
          What was Maha Katabi's most profitable transaction?
          Maha Katabi’s most profitable transaction was an Informative Buy of VERA stock on May 18, 2021. The return on the trade was 32.80%.
            What is Maha Katabi's role in Vera Therapeutics?
            Maha Katabi's role in Vera Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.